Outcomes for Lumbar Decompressions With Use of Liposomal Bupivicaine

Description

Evaluate the benefit of using liposomal bupivicaine in lumbar laminectomies in terms of length of stay, IV narcotic use, 30-day narcotic use, visual analog score (VAS) and 30-day readmissions

Conditions

Lumbar Spinal Stenosis

Talk to us

Study Overview

On this page

Study Details

Study overview

Evaluate the benefit of using liposomal bupivicaine in lumbar laminectomies in terms of length of stay, IV narcotic use, 30-day narcotic use, visual analog score (VAS) and 30-day readmissions

A Double Blinded Randomized Control Trial in Outcomes for Lumbar Decompressions With Use of Liposomal Bupivicaine

Outcomes for Lumbar Decompressions With Use of Liposomal Bupivicaine

Condition
Lumbar Spinal Stenosis
Intervention / Treatment

-

Contacts and Locations

Aurora

University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States, 80045

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Male or Female
  • 2. Adult (≥18 yo)
  • 3. Lumbar stenosis
  • 1. Co-morbidities precluding surgery
  • 2. ≤18 yo
  • 3. Pregnant
  • 4. Breastfeeding
  • 5. Need for instrumented fusion
  • 6. Prisoners
  • 7. Intra-operative CSF leak (identified by gush of CSF)
  • 8. Daily pre-operative opioid use of \> 25 morphine Eq/day
  • 9. Previous lumbar surgery at indicated level

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Colorado, Denver,

Study Record Dates

2025-01